Latest filings (excl ownership)
25-NSE
Exchange delisting
19 Jul 22
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
3 Jun 22
8-K
Termination of a Material Definitive Agreement
2 Jun 22
8-K
Departure of Directors or Certain Officers
18 May 22
10-Q
2022 Q1
Quarterly report
13 May 22
8-K
Zosano Pharma Reports First Quarter 2022 Financial Results
13 May 22
8-K
Departure of Directors or Certain Officers
5 May 22
8-K
Zosano Pharma Provides Corporate Update
29 Apr 22
10-K/A
2021 FY
Annual report (amended)
29 Apr 22
8-K
Zosano Pharma Announces Reverse Stock Split Effective Today
11 Apr 22
S-8
Registration of securities for employees
1 Apr 22
10-K
2021 FY
Annual report
17 Mar 22
8-K
Zosano Pharma Reports Fourth Quarter and Fiscal Year 2021 Financial Results
17 Mar 22
DEF 14A
Definitive proxy
25 Feb 22
8-K
Other Events
18 Feb 22
PRE 14A
Preliminary proxy
14 Feb 22
DEF 14A
Definitive proxy
11 Feb 22
8-K
Entry into a Material Definitive Agreement
9 Feb 22
424B5
Prospectus supplement for primary offering
9 Feb 22
424B5
Prospectus supplement for primary offering
8 Feb 22
8-K
Other Events
31 Jan 22
8-K
Other Events
24 Jan 22
8-K
Other Events
5 Jan 22
8-K
Departure of Directors or Certain Officers
13 Dec 21
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
30 Nov 21
8-K
Zosano Pharma Announces the Successful Formulation of a COVID-19 Vaccine Candidate on its Microneedle Patch System
17 Nov 21
10-Q
2021 Q3
Quarterly report
10 Nov 21
8-K
Zosano Pharma Reports Third Quarter 2021 Financial Results
10 Nov 21
8-K
Other Events
29 Oct 21
8-K
Departure of Directors or Certain Officers
6 Oct 21
8-K
Zosano Pharma Granted Type C Meeting with FDA Regarding NDA Resubmission for M207 Following Preliminary Top-Line Pharmacokinetic Study Results
4 Oct 21
10-Q
2021 Q2
Quarterly report
10 Aug 21
8-K
Zosano Pharma Reports Second Quarter 2021 Financial Results
10 Aug 21
EFFECT
Notice of effectiveness
15 Jul 21
CORRESP
Correspondence with SEC
12 Jul 21
UPLOAD
Letter from SEC
9 Jul 21
8-K
Submission of Matters to a Vote of Security Holders
2 Jul 21
S-3
Shelf registration
2 Jul 21
8-K
Entry into a Material Definitive Agreement
28 Jun 21
424B5
Prospectus supplement for primary offering
28 Jun 21
Latest ownership filings
4
Christine Matthews
7 Jun 22
4
Steven Lo
7 Jun 22
SC 13G
Five Narrow Lane LP
18 May 22
4
Christine Matthews
1 Apr 22
4
DONALD J KELLERMAN
1 Apr 22
4
Steven Lo
1 Apr 22
4
Elaine Yang
9 Dec 21
3
Elaine Yang
9 Dec 21
4
KENNETH GREATHOUSE
24 Nov 21
4
DONALD J KELLERMAN
19 Oct 21
4
Christine Matthews
19 Oct 21
4
Steven Lo
19 Oct 21
4
Linda Grais
14 Jun 21
4
STEVE ELMS
14 Jun 21
4
KENNETH GREATHOUSE
14 Jun 21
4
KLEANTHIS G XANTHOPOULOS
14 Jun 21
4
Joseph P Hagan
14 Jun 21
4
Steven Lo
7 Jun 21
4
Hayley Lewis
7 Jun 21
4
DONALD J KELLERMAN
7 Jun 21
4
Christine Matthews
7 Jun 21
4
Kathy M. McGee
25 May 21
3
Kathy M. McGee
25 May 21
4
KENNETH GREATHOUSE
18 May 21
4
Steven Lo
1 Apr 21
4
Hayley Lewis
1 Apr 21
4
DONALD J KELLERMAN
1 Apr 21
4
Christine Matthews
1 Apr 21
4
Steven Lo
19 Mar 21
SC 13G/A
SABBY MANAGEMENT, LLC
5 Jan 21
4
Linda S Grais
29 Jun 20
4
STEVE ELMS
29 Jun 20
4
Hayley Lewis
29 Jun 20
4
Steven Lo
29 Jun 20
4
DONALD J KELLERMAN
29 Jun 20
4
Christine Matthews
29 Jun 20
4
KLEANTHIS G XANTHOPOULOS
29 Jun 20
4
JOHN PETER WALKER
29 Jun 20
4
Joseph P Hagan
29 Jun 20
4
KENNETH GREATHOUSE
29 Jun 20